Labshake search
Citations for R&D Systems :
1 - 41 of 41 citations for PD L1 since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2020Quote: ... Soluble PD-L1 (sPD-L1) was from R&D systems (Minneapolis, MN, USA), Nivolumab was kindly provided by S ...
-
bioRxiv - Bioengineering 2021Quote: ... or PD-L1 (R&D systems, #156-B7) were applied to the sensors using a spotter (Scienion ...
-
bioRxiv - Cancer Biology 2022Quote: ... and PD-L1/B7-H1 (R&D Systems, AF1019-SP ...
-
bioRxiv - Immunology 2021Quote: ... Goat PD-L1 polyclonal antibody (#AF156, R&D Systems) was firstly conjugated with gold NPs using a gold conjugation kit (#ab201808 ...
-
Neutralizing PD-L1 and PD-L2 Enhances the Efficacy of Immune Checkpoint Inhibitors in Ovarian CancerbioRxiv - Cancer Biology 2020Quote: ... αHuman PD-L1 1:500 (#AF154, R&D systems,
-
bioRxiv - Cancer Biology 2020Quote: N-deglycosylation of recombinant PD-L1 (R&D Systems) was performed using PNGase F (New England Biolabs ...
-
bioRxiv - Synthetic Biology 2023Quote: ... PD-1-DNR interaction with PD-L1 was assessed by staining with 1 μg Recombinant Mouse PD-L1/B7-H1 Fc Chimera Protein (R&D Systems, 1019-B7-100), followed by anti-hFc antibody.
-
bioRxiv - Cancer Biology 2020Quote: ... anti-PD-L1 PE conjugated (R&D Systems cat no: FAB1561P), anti-PD-L1 (Cell Signaling ...
-
bioRxiv - Immunology 2022Quote: ... Recombinant human PD-L1 protein (R&D Systems, Cat# 156-B7) was used to make the standard curve ranging from 0.3125 to 10 ng/ml.
-
bioRxiv - Cancer Biology 2019Quote: ... mouse PD-L1 (R&D systems, AF1019, 1:500, Minneapolis, MN, USA), p-RB (Cell Signaling Technology ...
-
bioRxiv - Immunology 2023Quote: ... recombinant human PD-L1 human IgG1 Fc chimera protein (R&D Systems), or mouse IgG1 isotype antibodies (R&D Systems ...
-
bioRxiv - Cancer Biology 2020Quote: Secreted form of PD-L1 protein (Phe19-Thr239, R&D System # 9049-B7) was diluted in 50 mM Tris ...
-
bioRxiv - Cancer Biology 2022Quote: ... and PD-L1 (Cat. No. AF 1019) from R&D systems (Minneapolis, MN). HRP- linked anti-rabbit IgG ...
-
bioRxiv - Immunology 2021Quote: ... wells were coated with 30 μg/mL PD-L1-Fc chimera protein (R&D Systems) or 6 μg/mL anti-ICOS (clone C398.4A ...
-
bioRxiv - Immunology 2022Quote: ... 6.25 ng pMHC and 6.25 ng recombinant mouse PD-L1 with 6-His tag (R&D systems) in 2% BSA were injected into each well in this step ...
-
bioRxiv - Immunology 2024Quote: ... following reagents were used in flow cytometry: recombinant human PD-L1 Fc chimera Biotin protein (R&D Systems); APC Streptavidin (Tonbo Biosciences) ...
-
Neutralizing PD-L1 and PD-L2 Enhances the Efficacy of Immune Checkpoint Inhibitors in Ovarian CancerbioRxiv - Cancer Biology 2020Quote: ... equilibrium binding sorts were performed in which yeast were incubated at room temperature in phosphate buffered saline with 0.1% BSA (PBSA) with the following nominal concentrations of PD-L1 (R&D Systems): sort 1 ...
-
bioRxiv - Immunology 2020Quote: ... The expression of PD-L1 and IL-6 from bronchoalveolar lavages was quantitated following the protocols of ELISA kits: Human IL-6 Quantikine ELISA Kit and Human/Cynomolgus Monkey B7-H1/PD-L1 Quantikine ELISA Kit from R&D Systems.
-
bioRxiv - Cancer Biology 2020Quote: ... with C-terminal 6xHis tag produced in HEK293 cells and human recombinant PD-L1-Fc chimera protein produced in mouse NS0 cells were obtained from R&D Systems, Minneapolis ...
-
bioRxiv - Bioengineering 2023Quote: PD-L1 was detected in K562 or THP-1 EVs using the Human PD-L1 DuoSet ELISA kit and DuoSet ELISA Ancillary Reagent Kit 2 (R&D Systems) according to the manufacturer’s instructions ...
-
bioRxiv - Cancer Biology 2020Quote: ... The cells were harvested after treatment and stained for PD-L1 (eBioscience, 12-5983-42) and MHC class I (R&D Systems, FAB7098G). Induction of the respective proteins was analyzed by flow cytometry.
-
bioRxiv - Cancer Biology 2024Quote: ... Sections from formalin-fixed paraffin-wax embedded tumours were stained with primary rat anti-mouse monoclonal anti-CD8 antibody (eBioscience, 4Sm15as) and goat anti-mouse polyclonal anti-PD-L1 antibody (R&D systems, AF1019). Slides were scanned and imaged using Hamamatsu Nanozoomer (Hamamatsu Photonics).
-
bioRxiv - Immunology 2021Quote: ... and either 7µg of Recombinant PD-L1/B7-H1 Fc Chimera Protein (mouse: R&D System 1019-B7; human: R&D System 156-B7) (indicated as anti-CD3/28-PDL1-beads ...
-
bioRxiv - Immunology 2021Quote: ... and either 7µg of Recombinant PD-L1/B7-H1 Fc Chimera Protein (mouse: R&D System 1019-B7; human: R&D System 156-B7) (indicated as anti-CD3/28-PDL1-beads ...
-
bioRxiv - Immunology 2021Quote: ... and SDF-1a), and other factors (PD-L1, PDGF-BB, S100B, GM-CSF, and VEGF-A) validated for NHP (R&D Systems, Minneapolis, MN, USA). Standard curves were generated using 5-parameter logistic regression using the xPONENT™ software provided with the MAGPIX instrument (Luminex ...
-
bioRxiv - Immunology 2023Quote: Serum and recombinant PD-1 was quantified by human PD-1 Quantikine ELISA and human PD-1 DuoSet ELISA (R&D Systems, Minneapolis, MN), following manufacturer’s protocol ...
-
bioRxiv - Cancer Biology 2024Quote: ... samples were treated with recombinant human PD-1 Fc protein (1086-PD-050, R&D System) at 4 °C overnight ...
-
bioRxiv - Immunology 2022Quote: ... PD-1 Ig (R&D Systems), CTLA-4 Ig (Abatacept ...
-
bioRxiv - Cancer Biology 2021Quote: ... The mPD-L1 protein bought from R&D Systems was used for four rounds of panning ...
-
bioRxiv - Bioengineering 2021Quote: ... To create multiple loading densities a series of concentrations of PD-1 (R&D systems, #8986-PD) or PD-L1 (R&D systems ...
-
bioRxiv - Physiology 2020Quote: ... PD-1 blocking antibody (R&D Systems/Techne, #AF1086) was included at the 10 µg/ml ...
-
bioRxiv - Biochemistry 2021Quote: ... recombinant glycoproteins (R&D Systems 1658-PD and 3345-PS) were digested overnight with mucinase SmEnhancin (38 ...
-
bioRxiv - Cancer Biology 2022Quote: ... recombinant mouse PD-1-Fc chimeric protein (R&D Systems) or human IgG1 control (R&D Systems) ...
-
bioRxiv - Cancer Biology 2023Quote: ... or mouse rPD-1-Fc (R&D Systems #1021-PD-100) for 0 ...
-
bioRxiv - Biochemistry 2023Quote: Aliquots containing 10 µg of podocalyxin (R&D Systems, 1658-PD) recombinantly expressed in NS0 cells were reconstituted at a concentration of 1 µg/µL in 50 mM AmBic and subjected to different mucinase treatments ...
-
Neutralizing PD-L1 and PD-L2 Enhances the Efficacy of Immune Checkpoint Inhibitors in Ovarian CancerbioRxiv - Cancer Biology 2020Quote: ... and resuspended in PBSA containing a ∼50 fold molar excess of PD-1 (R&D Systems) to render unbinding events irreversible ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... MA) and recombinant mouse PD-1 His-tag protein was from R&D Systems (Minneapolis, MN). Glycine ...
-
bioRxiv - Immunology 2022Quote: ... PE-conjugated anti-CTLA-4 and APC-conjugated anti-CD279 (PD-1) were purchased from R&D System (Minneapolis, MN). Human cytokines from cell culture supernatants were analyzed using ELISA kits for TNF ...
-
bioRxiv - Biophysics 2022Quote: ... ECD fragments (modified C-terminally with 10xHis tag) Podocalyxin (PODXL) (Cat.# 1658-PD) and PODXL2 (Cat.# 1524-EG) were obtained from R&D Systems. The ECD fragments were dissolved in ultrapure water to a concentration of 0.5 mg/mL and aliquoted in 50 μL ...
-
bioRxiv - Cancer Biology 2023Quote: ... caspase-3 and PARP cleavage were determined by Western Blot analysis while levels of PAR in the tumor lysates were determined by ELISA using the HT PARP in vivo PD Assay II Kit [4520-096-K] from R&D Systems. The remaining mice were measured twice weekly in three dimensions using Vernier calipers and the volume estimated using the formula (width x length x depth x 0.524mm3) ...
-
bioRxiv - Cancer Biology 2023Quote: ... cells were treated with 1 μg/mL of either human rPD-1 (hrPD-1-Fc; R&D Systems #1086-PD-050; Minneapolis, MN, USA) or mouse rPD-1-Fc (R&D Systems #1021-PD-100 ...